Trial and Error and Algorithm
Cardiovascular Drugs: Classification based on Therapeutic Indications
Global Climate Change
Rates of Change
Work Done During Volume Change
Data Reporting and Recording
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 9, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Tamás Biernacki1, Krisztina Bencsik1, Zsigmond Tamás Kincses1
1Szegedi Tudományegyetem, Általános Orvostudományi Kar, Szent-Györgyi Albert Klinikai Központ, Neurológiai Klinika, Szeged.
Alemtuzumab demonstrates therapeutic potential as a first or second-line treatment for highly active autoimmune diseases, showing efficacy in two distinct patient cases. This highlights alemtuzumab
Area of Science:
Background:
Observation:
Findings:
Implications: